Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.21B 590M 506M 475M 434M 819M 56.23B 823M 5.62B 2.18B 28.37B 2.17B 93.96B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.24B 597M 513M 481M 440M 830M 56.98B 834M 5.7B 2.21B 28.75B 2.19B 95.22B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day+2.17%
1 week+7.00%
Current month+9.78%
1 month+6.37%
3 months+6.73%
6 months+6.46%
Current year-0.15%
1 week 58.85
Extreme 58.85
63.45
1 month 57.55
Extreme 57.55
63.45
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
79.09
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 04/09/2018
Director of Finance/CFO - 10/03/2024
Chief Tech/Sci/R&D Officer 51 31/12/2022
Director TitleAgeSince
Chairman 54 09/04/2022
Director/Board Member 45 12/09/2023
Director/Board Member 45 09/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%+7.00%-14.26% - 579M
-1.17%-0.03%+18.70%+70.05% 48.37B
+1.12%+1.41%+54.88%+122.68% 39.88B
-1.36%-1.36%-11.21%+14.14% 12.05B
+2.27%+4.12%+16.41%+81.30% 11.77B
+0.19%0.00%+30.98%+150.00% 9.19B
-0.45%+3.26%+24.53%+45.36% 7.87B
+1.30%+1.26%+54.43%-10.73% 7.25B
+1.60%+8.54%+25.00%+217.84% 7.1B
+0.95%-8.22%-39.88%+16.67% 5.26B
Average +0.66%+1.14%+15.96%+78.59% 14.93B
Weighted average by Cap. +0.16%+1.18%+26.67%+85.38%

Financials

2024 2025
Net sales 394M 105M 90.07M 84.54M 77.21M 146M 10.01B 146M 1B 388M 5.05B 385M 16.72B 460M 123M 105M 98.8M 90.24M 170M 11.7B 171M 1.17B 453M 5.9B 450M 19.55B
Net income 79.85M 21.27M 18.25M 17.13M 15.65M 29.53M 2.03B 29.67M 203M 78.57M 1.02B 78.12M 3.39B 97.01M 25.84M 22.18M 20.81M 19.01M 35.88M 2.46B 36.05M 246M 95.46M 1.24B 94.9M 4.12B
Net Debt 42.83M 11.41M 9.79M 9.19M 8.39M 15.84M 1.09B 15.92M 109M 42.15M 549M 41.9M 1.82B 29.47M 7.85M 6.74M 6.32M 5.78M 10.9M 749M 10.95M 74.84M 29M 378M 28.83M 1.25B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
26/08/26 SAR 63.45 +2.17% 153,124
25/08/26 SAR 62.10 -1.04% 74,011
24/08/26 SAR 62.75 +1.21% 157,698
23/08/26 SAR 62.00 +0.81% 106,139
20/08/26 SAR 61.50 +3.71% 185,854
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
63.45SAR
Average target price
146.40SAR
Spread / Average Target
+130.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock